Video Case Solution: Nephrogenic Systemic Sclerosis (NSS)
A 50-year-old woman with chronic renal failure and has been on hemodialysis for five years. She had multiple gadolinium enhanced MRIs for chronic low back pain. She developed inability to raise arms and legs that evolved over six months. She had no dysphagia. She was found to have hard skin and breasts and her CK level and EMG were normal. Watch the video: http://bmctoday.net/practicalneurology/videos.asp?f=video8
The most likely diagnosis is:
Scleroderma
Polymyositis
Nephrogenic systemic sclerosis (NSS)
Polymyalgia rheumatica
Systemic calcinosis
NEPHROGENIC SYSTEMIC SCLEROSIS (NSS)
- NSS is a dramatic hardening of the skin and subcutaneous tissue that is reported in uremic patients who get gadolinium contrast. The deposited mucin, collagen, and elastic fibers are produced by activated fibroblasts.
- There is evidence that sclerosis goes beyond the skin and subcutaneous tissue. Muscle involvement is documented. Reported axonal neuropathy may also be related to uremia.
- CK level is usually low due to decreased muscle mass and EMG is either normal or shows mixed short and long duration units consistent with chronic myopathy.
- Other disorders with similar picture include amyloidosis, scleromyxedema, systemic sclerosis, eosinophilic fasciitis, and graft vs. host disease, which should be considered.
- The exact pathogenesis is not clear and some patients with uremia develop NSS without being exposed to gadolinium.
- Renal transplantation may improve outcome, otherwise, there is no cure for this condition. Steroids, PLEX, and IVIG are reported to cause transient improvement.
Neuromuscular involvement in nephrogenic systemic fibrosis. Keyrouz S, Rudnicki SA.J Clin Neuomuscul Dis. 2007 Dec;9(2):
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Neuromuscular
Digital Biomarkers in Neuromuscular Disorders: Recent Advances
Stephen A. Johnson, MD; Andrew Geronimo, PhDStephen A. Johnson, MD; Andrew Geronimo, PhD - Neuromuscular
Imaging Outcome Measures in Neuromuscular Diseases
Oliver J. Ziff, MB, ChB, PhD; Jasper M. Morrow, MB, ChB, PhDOliver J. Ziff, MB, ChB, PhD; Jasper M. Morrow, MB, ChB, PhD - Neuromuscular
Neuromuscular Disorders: Clinical and Functional Measurements
Reza Sadjadi, MD; Christopher R. Cashman, MD, PhDReza Sadjadi, MD; Christopher R. Cashman, MD, PhD